Retroviruses isolated from mammalian species have 3'-LTR (long terminal repeat) promotion of a downthe potential to provide valuable basic information on stream oncogene," a relatively rare event occurring the etiology and mechanism(s) of cancer induction by only in c-myc activation in avian B-cell lymphomas. viruses. They may also serve as models for evaluating All proviruses involved in this type of activation suffer antiviral agents prior to human clinical trials. The oc-from deletions in either the viral promoter or the 5'currence of neoplastic sequelae in retrovirus-infected LTR or a deletion of internal sequences that disrupt animals supports the view that these viruses may be LTR function. These types of deletions result in the directly or indirectly involved in the etiology of those shut-off of the 5'-LTR function and deregulated tranmalignancies. The identification and development of scription of the 3'-LTR and contiguous cellular sesuitable animal models of viral neoplasia may aid in quences, such as c-myc. 5'-LTR promotion, the second understanding cancer initiation and progression, ulti-mode of activation, occurs when the 5'-LTR viral promately providing a better understanding of the role of moter is utilized in a read-through mechanism in which viruses in the etiology of human cancer. However, re-viral genes are transcribed and spliced to cellular sesearch progress on viral-associated malignancies in do-quences, leading to a truncation of the viral coding mesticated animals has been hampered because of the sequences and subsequent expression and cellular 10indolent nature of the disease, the limited number of calization ofthe truncated viral protein. A third mechanimals that develop malignancies, and the diversity anism of insertional activation is enhancer insertion. of viruses that may serve as etiologic factors or cofac-At least 40 common insertion sites associated with tors. To assess the current state of knowledge ofretro-retrovirus-induced tumors have been identified since viral infections in animals and the etiology of neo-the discovery of c-myc activation in avian leukosis plasms in domesticated animals and to identify areas virus lymphomas. One-third of the sites are homologs of research that might require stimulation or resources of known viral oncogenes, and the remaining sites that would be necessary for continued progress, the demonstrate growth-signaling or transforming prop-National Cancer Institute (NCI) convened a workshop erties. Dr. Kung discussed examples of the mechaentitled "Animal Models of Retrovirus-Associated nisms of retroviral oncogenesis in avian and small an-Malignancies" on 15 November 1990 in Bethesda, imal models, including viral and host factors influencing Maryland. Dr. Myron Essex, of the Harvard School of the choices of mutagenesis mechanisms and the modes Public Health and a member of the Division of Cancer of activation of different classes of oncogenes. Etiology Board of Scientific Counselors, chaired the The equine infectious anemia virus (EIAV) is a useworkshop.
The recurrent episodes of viremia continue at irregular intervals separated by weeks or months. The major immune responses are directed against viral surface glycoproteins, although there are also significant antibody and cell-mediated responses to the core proteins, Distinct antigenic strains of EIAV arise during each sequential disease episode and recurring viremia. EIAV is unique among the lentiviruses because it is the only virus in which host immunologic control of infection is observed. In his remarks, Dr. Ronald Montelaro (University of Pittsburgh School of Medicine, Pittsburgh, PA) pointed out the distinct virtues of the EIAV model for investigations of immunopathogenesis, lentivirus biology, and experimental vaccine strategies. 5, 27, 2933 Much current EIAV research focuses on defining antigenic sites on the viral surface glycoproteins and the kinetics of antibody and cell-mediated immune responses as the animal progresses from chronic EIA to the persistent and inapparent state of infection. The target cells for EIA V infection appear to be exclusively cells of the monocyte/macrophage lineage with no evidence of lymphocyte involvement. EIAV replicates mainly in liver, spleen, and kidney, presumably organs where macrophages are concentrated. It was suggested that future research should include an expanded effort to develop equine-specific immunologic and molecular reagents to better define the cellular targets of infection and should include increased support to develop continuous monocyte/macrophage cell lines in which to propagate infectious pathogenic strains of EIAV. Because molecular clones of EIAV will produce a persistent infection but fail to induce clinical disease symptoms in animals, additional efforts will be required to derive infectious molecular clones that induce EIA V disease.
Bovine leukemia virus (BLV), a naturally occurring exogenous B-Iymphotropic retrovirus of cattle.v" is involved in disease processes, persistent lymphocytosis (PL),24 a nonneoplastic B-cell proliferation, enzootic bovine leukosis, and a neoplastic proliferation of B-lymphocytes. Sheep are susceptible to BLV infection," and following experimental inoculation, they develop lymphosarcomas at an increased rate compared with that of the naturally occurring infection in cattle." In the bovine, a polyclonal proliferation of infected B-lymphocytes and integration of the BLV provirus occurs during PL. 24 There are no preferential sites for proviral integration; both monoclonal and oligoclonal disease are detected during BLV tumorigenesis. Although BLV infection is required for tumor induction, once tumor cells have developed, expression of viral genes is no longer required for tumor progression." Dr. Arsene Burny (University of Brussels, Brussels, Belgium) described a novel fibroblast tissue culture system in which the expression of the BLV tax transactivator protein alone is sufficient to immortalize fibroblasts, but tax is unable to morphologically transform the cells. However, the BLV tax gene plus an activated ras gene lead to a morphologically transformed state in the target fibroblast, indicating the possible requirement for two distinct events for transformation by BLV. Although BLV-infected animals may express a high level of neutralizing antibody against the virus, the animals' immune systems are unable to control the cell-to-cell spread ofinfectious virus through fusion mechanisms. Thus, during leukemogenesis, the BLV tax protein is involved in transactivation; however, the virus is necessary but not sufficient for progression to tumorigenesis. Continued research is needed to determine the molecular mechanism of BLV transformation and the interaction(s) of BLV-encoded proteins with normal cell proteins.
A bovine lentivirus similar to human immunodeficiency virus (HIV), the bovine immunodeficiencylike virus (ElV), was isolated in 1969 from an 8-yearold cow with persistent lymphocytosis, progressive weakness and emaciation, lymph node hyperplasia, and mild lymphocytic perivascular cuffing in the brain." In spite of serologic evidence of ElV infection in 5-10% of animals in some domestic herds in the United States," the long-term effects of'BlV infection have not been adequately investigated and little is known about ElV involvement in the etiology of bovine malignancies. In the first few months following infection ofcalves with BIV,2 a moderate nonpersistent lymphocytosis and lymph node hyperplasia is observed. However, when immunologic parameters in BIV-infected animals were evaluated (as detailed by Dr. James Roth, Iowa State University, Ames, IA), no significant alterations in lymphocyte subset distribution, blastogenic responses, or neutrophil function were observed through 2 years post-infection. These results indicate that the appearance of clinical signs and immunologic evidence of BlV-associated immunosuppression or disease may require longer periods following infection, more virulent ElV isolates to induce a more rapid disease course, or the presence of other microbial cofactors. Additional field isolates of BIV should clarify whether viral attenuation occurs during in vitro propagation of ElV or whether other strains of ElV demonstrate markedly different patterns of virulence. Because cattle in herds may have subclinical or undiagnosed persistent viral or bacterial infections that could influence the course ofBIV infection, preexisting microbial infections might alter BIV pathogenesis or cause alterations in immunologic parameters prior to experimental BIV infection. Although potential interactions between ElV and BLV have not been adequately explored, recent experiments indicate that coinfection of cattle with both ElV and BLV caused a Vet Pathol 29:6, 1992 more marked lymphocytosis than would be expected from infection by either virus alone. The long-term effects of BIV infection have not been well characterized, and the etiologic role ofBIV as a factor or cofactor in the etiology of viral oncogenesis remains to be determined.
An exogenously acquired retrovirus is believed to be an etiologic factor in ovine pulmonary carcinoma (OPC, sheep pulmonary adenomatosis). 8.32,40 Sheep with OPC exhibit rapid breathing and loss of physical condition and have a nasal discharge that originates within the lung, probably as a product of the tumor cells, and contains virus particle-associated reverse transcriptase (RT), Dr. James C. DeMartini (Colorado State University, Fort Collins, CO) surveyed the morphologic, biochemical, and immunologic evidence concerning the association of a type D retrovirus with OPC and discussed recent efforts to isolate and propagate molecular clones of these viruses. OPC resembles human lung carcinomas and is classified pathologically as a bronchioloalveolar carcinoma (BAC). OPC originates from pulmonary type II alveolar epithelial cells or nonciliated bronchiolar (Clara) cells" and demonstrates a 10% rate of metastasis to regional lymph nodes. The counterpart human lung cancers are also bronchial or alveolar epithelial cell carcinomas, a subform of adenocarcinoma of the lung; about half of these cancers produce mucus and are of probable goblet cell origin, whereas the other half are similar to the OPC model. The incidence of this subcategory of human lung tumors is increasing in the United States. The tumor in humans is a solitary mass, arising peripherally with multicentric nodules throughout the lung fields, similar to that observed in diseased sheep. In the newborn lamb model, lung disease develops within 3 weeks after transtracheal inoculation with ultracentrifuged tumor tissue or lung fluid extracts containing RT activity, with greater than 75% of inoculated lambs developing pulmonary carcinoma lesions within 6 months." Type D retrovirus-related capsid proteins were detected in ovine tumor extracts using reagents based on the Mason-Pfizer monkey virus (MPMV),19,36 the prototype type D retrovirus. Additionally, an ovine type C lentivirus (OvLV) is suggested as a potential etiologic cofactor because of the consistent presence of OvLV in natural and experimental OPC cases in North and South America." Recently observed nasal carcinomas in goats' are similar to the ovine disease with a nasal discharge but demonstrate a locally invasive nonmetastatic epithelial tumor phenotype. Similar to the OPC model, type D virus particles were observed in electron micrographs of goat tumor tissue, and antibody to virion proteins, cross-reacting with type D virus, was detected. In contrast to other retroviral models involving leukemia/lymphoma viruses, the sheep and goat malignancies are the only known animal models in which experimentally induced carcinomas occur. Lung cancer is one of the most common of human malignancies and the prevalence of carcinomas in human beings exceeds hematopoietic neoplasms. Dr. DeMartini suggested that increased research on these models should emphasize the isolation and characterization of etiologic agent(s) and cofactors, the preparation of molecular, biological, and immunologic reagents for pathogenic investigations, and further studies of the natural mode of transmission and the mechanism(s) of oncogenesis.
The feline leukemia virus (FeLV) system offers an excellent model to study how naturally occurring and laboratory transmitted retroviruses induce anemia, immunosuppression, and neoplastic transformation. '8, 35 FeLV, the etiologic agent of feline lymphomagenesis, is transmitted by biting and salivary transfer.13,15 Dr. Edward Hoover (Colorado State University) discussed a number of possible outcomes of FeLV infection. The genotype ofthe infecting virus(es) and the efficacy of the host immune response are pivotal in determining the outcome of infection. Naturally occurring FeLV has three envelope antigenic types: A, B, and C. 38 FeLV-A is found in nature as a single antigenic type, and FeLV-B and FeLV-C are always found in association with FeLV_A. 43 There is evidence that subgroup FeLV-B and FeLV-C viruses arise through recombination of FeLV -A with cat endogenous FeLVrelated sequences." The progression of virus infection during the first 2 to 6 weeks after virus exposure involves early replication in macrophages, local and systemic T-and B-lymphocytes, hemopoietic progenitor cells, and mucosal epithelia." A persistent FeLV viremia and antigenemia may be followed by disease in which neutralizing antibody is not formed and little viral containment occurs. Preleukemic events in persistently antigenemic animals include thymic atrophy, CD4 lymphocyte depletion, and immunosuppression. In most instances, the transient FeLV infection is followed by an effective immune response and containment of virus replication. FeLV disease incidence following infection is extremely low if the virus is maintained in the proviral state and not expressed and is accompanied by neutralizing and cell surface antibody. FeLV can also cause proliferative and antiproliferative diseases such as lymphomas, immunodeficiency syndrome, aplastic anemia, and myelogenous Ieukemia.v-" FeLV -C is associated with anemias, The lentivirus feline immunodeficiency virus (FlV), distantly related to HIV and simian immunodeficiency virus (SIV), induces a fatal immunodeficiency disease in cats. The major mode ofFlV transmission is similar to that of FeLV, through saliva and biting. 50 Dr. Niels Pedersen (University of California, Davis, CA) noted that nearly one-third of the FlV-infected animals that he has observed in veterinary clinics display symptoms associated with feline AIDS or feline AIDS-related complex, including immunodeficiency and multiple opportunistic infections. However, nearly 10% of the FlV-infected cats are diagnosed with neoplastic sequelae as the sole or predominant illness. Recent natural history studies suggest that some tumors occur in FlV-infected cats much more often than can be accounted for by chance alone. 1,41 Lymphoid (lymphosarcomas) and myeloid (myelogenous leukemias) malignancies are strongly associated with FIV infection, occur most frequently in cats older than 6 years, and occur more frequently in males than females, and the cancers are often solitary in nature. This pattern is strikingly different from that observed with FeLV-associated lymphomas, which occur about equally in both sexes and are observed more often in cats from 1 to 5 years ofage. Because from 15% to 30% ofFlV-infected cats are coinfected with FeLV, the possible role of dual FeLV and FlV infections in the etiology of these cancers must be considered. FeLV is an etiologic factor or cofactor in about 70% of the cases of lymphoma and myeloproliferative diseases. Evidence from natural history studies indicates that the relative risk of developing leukemia/lymphoma was 5, 62, and 77 times greater in cats infected with FIV, FeLV, or FlV + FeLV, respectively," indicating that FeLV and FlV could act synergistically in the etiology ofthese cancers. Further research should be conducted to determine whether FlV is an oncogenic virus or how it might be involved in oncogenic processes, whether FIV increases cancer incidence by decreasing the efficiency of tumor immunosurveillance mechanisms, and whether coinfection of animals with FlV and FeLV results in synergistic interactions and increased tumor incidence.
The recently discovered simian T-lymphotropic virus (STLV) and immunodeficiency virus (SIV) are excellent animal models for investigations of virus-associated human disease and malignancies. 17.22,23 STLV is related to HTLV-l, the etiologic agent of human adult T-cell leukemia,20 and naturally infects Old World monkeys and great apes. Dr. Phyllis Kanki (Harvard School of Public Health, Boston, MA) reviewed captive animal studies that demonstrated an association of STLV with spontaneous lymphoid malignancies in macaques and an adult T-cell leukemia (ATL)-like disease observed in African green monkeys. Although SIV induces an immunosuppressive disease in captive Asian macaques that is similar to human AIDS,21 the distribution of SIV in primate species in the wild remains unclear. Animals believed to be infected include African cercopithecine and Papio species, although baboons have shown rare infection with SIV. Because there is no convincing evidence that wild Asian macaques are infected with SIV, the outbreaks of immunodeficiency seen in US primate centers from 1979 to 1983 probably were due to the exposure of captive Asian macaques to healthy but inapparently infected African monkeys. Although lymphoid malignancies have been observed in infected animals, it is not known if SIV is etiologically linked to these cancers or if it predisposes the animals to other leukemogenic agents. These simian retroviruses will continue to be important models for understanding the mechanisms ofviral carcinogenesis in human beings.
Retroperitoneal and subcutaneous fibromatosis (RF/ SF) is an aggressive vascular proliferative disease that is pathologically and histologically similar to human Kaposi's sarcoma (KS). Because this disease was first observed in captive macaque colonies (Macaca nemestrina) at the Washington Regional Primate Research Center, a major focus ofresearch on this animal model has been to understand the possible etiologic role of the type D simian retrovirus serotype 2 (SRV-2) in RF/SF.3.44,46 SRV-2-infected macaques also demonstrate severe immune defects, opportunistic infections, and Bvcell lymphomas." Dr. Cheng C. Tsai (Deaconess Hospital, St. Louis, MO) compared and contrasted KS and RF/SF, noting that both are common AIDS neoplasms originating in mesenchymal cells and are highly vascular fibroproliferative disorders, Both neoplasms are associated with retrovirus infections (HIV-1 and SR V-2), which are etiologically linked to immunosuppressive disorders. Both KS and RF frequently involve lymph nodes and the interleukin-6 cytokine in auto-Vet Pathol 29:6, 1992 crine/paracrine growth mechanisms. In general, KS is more vascular and hemorrhagic than is RF/SF. KS is a multicentric dermal lesion, whereas RF/SF often originates in the lymph nodes adjacent to the intestine. The potential role of autocrine and/or paracrine cytokines in the proliferation of RF/SF cells will necessitate more research to determine whether the RF/SF cells behave similarly to human KS cells in culture. Additional research is also required to determine the presence or absence of a type D or other virus(es) in the RF/SF tissue. The analysis of the RF/SF system demonstrates the importance of this novel model for investigating the viral etiology and mechanisms ofsimian AIDS-associated neoplasms.
Research on animal retroviruses, from domestic animal and nonhuman primate species, provides valid models to investigate mechanisms of viral pathogenesis and the etiology of virus-associated neoplasms in human beings. With the exception of HIV-l, HIV-2, HTLV-1, and HTLV-2, there are no other reports of retroviruses detected in or isolated from human beings. However, there are malignancies of the human lymphoid system in which a viral etiology or cofactor is suspected. Human lymphoid malignancies have traditionally been classified into two pathologic groups: the Hodgkin's lymphomas, comprising various histopathologic forms of Hodgkin's disease (HD), and the non-Hodgkin's lymphomas (NHL), a heterogeneous group of nearly a dozen B-and T-cell lymphoid neoplasms." HD is considered a prototypic virus-associated human lymphoid neoplasm because of the morphologic characteristics of the diagnostic Reed-Sternberg cell, which resembles virally transformed lymphoid cells. Although sporadic reports ofretroviral association (HTLV -1 and -2) have appeared," a recent report also suggests the presence of Epstein-Barr virus in a significant percentage of HD lesions." In contrast to HD and NHL, AIDS-related lymphomas (ARL) are generally extranodal, exhibit extremely aggressive growth characteristics, and are refractory to conventional NHL chemotherapy. Dr. Richard Ford (M. D. Anderson Cancer Center, Houston, TX) described an unusual morphologic variant of Burkitt's lymphoma" that was observed in an ARL patient in Houston. The possible presence of virus(es) in the ARL cells was explored because of the close morphologic resemblance of the lymphoma cells to HIV-infected CD4+ T-lymphocytes. Ultrastructural evidence and reverse transcriptase (RT) analysis indicated that the ARL cells, established by tissue culture of fresh surgical biopsy specimens from the AIDS lymphoma, contained a retrovirus, but the virus morphology and RT substrate preference were not consistent with either the HIV or HTLV retroviruses. Results from polymerase chain reactions (PCR) provided strong evidence for the pres-ence of Mason-Pfizer monkey virus (MPMV)-like primate virus nucleic acid sequences'? in virus particles released from the patient's lymphoma cells; furthermore, amino acid sequences of the ARL virus p27 and p 14 core proteins confirmed their strong association with MPMV. In the past, the isolation and identification of new viruses in human tissues or cells has sometimes been hampered by the accidental laboratory contamination of cells or tissues with exogenous viruses. To exclude laboratory contamination as a possible source of the ARL virus, the patient's original diagnostic bone marrow specimens were tested using PCR technology, and MPMV-like sequences were detected. Antibodies to viral p27 and p14 were also identified in the patient's serum.' Recent natural history studies indicate that MPMV may be present in several population groups besides those at high risk for HIV infection. Although this evidence for human D type viral infection appears to be relatively strong and convincing, a number of caveats must be considered, including possible technical problems, that could be raised with respect to the data and their interpretation. Future research should address questions concerning the potential role for immunosuppressive MPMV-like or other viruses as a factor or cofactors in the etiology of human B-cell malignancies. If viruses are observed in other malignancies, the natural history of their transmission and the presence ofhuman reservoirs certainly must be investigated.
Dr. Myron Essex moderated the general workshop discussions and provided the overall summary addressing viral carcinogenesis animal model research that could benefit from further stimulation as well as the issue of what NCI resources might be needed to insure such stimulation. Based on the workshop discussions, as well as post-conference communications to NCI staff, it was apparent that a sufficient base of knowledge and technical expertise exists to undertake an expanded program on animal models of virus-associated human malignancies. Considerable enthusiasm was expressed concerning the diversity of diseases and pathology observed in these animal models, the quality of new information, and the opportunities to establish strong scientific collaborations. The NCI was encouraged to undertake additional and expanded scientific activities. In response to these recommendations, the NCI has issued a request for grant applications to stimulate extramural research activities in domestic animal models of viral carcinogenesis. Using retroviruses of large domesticated animals, increased emphasis will be placed on investigating the mechanisms ofcancer etiology, viral oncogenesis, and disease pathogenesis from the initial infection through the development of preneoplastic lesions and subsequent neoplastic sequelae. The NCI will encourage research to assess the role of the host immune system and host genetic factors in the control and limitation of virus replication and the susceptibility or resistance of animals to oncogenic processes, Investigations of the role of other RNA and DNA virus cofactors in cancer etiology will be encouraged as will studies on the expression and regulation of viral and/or cellular genes in preneoplastic lesions and malignant tissues from retrovirus-infected domestic animals, Animal models may aid in investigating the initiation and progression of neoplasia of viral origin and provide a better understanding of the role of viruses in the etiology of human cancers, Thus, expanded research emphasizing retroviruses of domesticated animals has the potential to provide valuable information on the mechanism(s) of cancer induction by viruses.
